The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Post hoc analysis in patients (pts) with unresectable hepatocellular carcinoma (uHCC) who progressed to Child-Pugh B (CPB) liver function in the phase III REFLECT study of lenvatinib (LEN).
 
Jasmine Huynh
No Relationships to Disclose
 
May Thet Cho
Consulting or Advisory Role - Amgen; Astellas Pharma; Eisai; Exelixis; Ipsen; Taiho Pharmaceutical
Speakers' Bureau - Taiho Pharmaceutical
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); incyte (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune
 
Edward Jae-Hoon Kim
Consulting or Advisory Role - Celgene; Eisai; Lilly
Speakers' Bureau - Celgene; Eisai
Research Funding - Astellas Pharma (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Dynavax Technologies (Inst); EpicentRx (Inst); ERYTECH Pharma (Inst); Eureka Therapeutics (Inst); Fibrogen (Inst); Halozyme (Inst); Merck (Inst); NGM BIOPHARMACEUTICALS (Inst); OncoMed (Inst); Samumed (Inst)
 
Min Ren
Employment - Eisai
 
Carol Robbins
Employment - Eisai
 
Carlos Amaya-Chanaga
Employment - Eisai; Pharmacyclics
Stock and Other Ownership Interests - Abbvie
 
Arndt Vogel
Honoraria - Amgen; Bristol-Myers Squibb; Delcath Systems; Ipsen; Janssen; Lilly; MSD; Novartis; Pierre Fabre; Roche; Sanofi
Consulting or Advisory Role - Amgen; AstraZeneca; Baxalta; Bayer; BTG; Eisai; IPSEN; Lilly; Novartis; Pierre Fabre; Roche
Research Funding - Novartis
Travel, Accommodations, Expenses - Bayer; Ipsen; Roche